You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
現代中藥集團(01643.HK)擬溢價配發1.2億股認購股份 總籌3240萬港元
格隆匯 04-09 06:47

格隆匯4月9日丨現代中藥集團(01643.HK)發佈公告,2025年4月8日,公司(作爲發行人)與認購人(即大健康(全球)投資基金管理有限公司)訂立認購協議,據此,認購人已有條件同意認購而公司已有條件同意以現金3240萬港元配發及發行合共1.2億股認購股份,認購價爲每股認購股份0.27港元。

假設公司的已發行股本於本公告日期至交割日期止期間內並無變動,認購協議項下的認購股份相當於(i)本公告日期公司現有已發行股本爲20.00%;及經配發及發行認購協議項下認購股份擴大後的已發行股本約16.67%。認購價每股認購股份0.27港元較2025年4月8日(即認購協議日期)於聯交所所報每股股份收市價0.260港元溢價約3.85%。

假設所有認購股份獲悉數認購,預期認購事項的所得款項總額將爲3240萬港元。認購事項的所得款項淨額亦爲3240萬港元,相當於每股認購股份淨價爲0.27港元。公司擬將有關所得款項淨額用作進一步投資及業務發展。所得款項淨額中的約50%將用於與中醫藥相關的新業務機會,包括投資中醫藥製造廠商;以及所得款項淨額中的約50%將用於爲持續提升研發能力提供額外資金。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account